Annual Shareholders Equity
-$56.51 M
-$133.28 M-173.60%
December 31, 2023
Summary
- As of February 7, 2025, BTAI annual stockholders equity is -$56.51 million, with the most recent change of -$133.28 million (-173.60%) on December 31, 2023.
- During the last 3 years, BTAI annual shareholders equity has fallen by -$263.20 million (-127.34%).
- BTAI annual shareholders equity is now -125.49% below its all-time high of $221.67 million, reached on December 31, 2021.
Performance
BTAI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$85.63 M
-$11.33 M-15.25%
September 30, 2024
Summary
- As of February 7, 2025, BTAI quarterly stockholders equity is -$85.63 million, with the most recent change of -$11.33 million (-15.25%) on September 30, 2024.
- Over the past year, BTAI quarterly shareholders equity has dropped by -$29.13 million (-51.54%).
- BTAI quarterly shareholders equity is now -132.02% below its all-time high of $267.41 million, reached on June 30, 2021.
Performance
BTAI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BTAI Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -173.6% | -51.5% |
| 3 y3 years | -127.3% | -134.9% |
| 5 y5 years | -245.3% | -348.8% |
BTAI Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -125.5% | at low | -138.6% | at low |
| 5 y | 5-year | -125.5% | at low | -132.0% | at low |
| alltime | all time | -125.5% | at low | -132.0% | at low |
BioXcel Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$85.63 M(+15.3%) |
| Jun 2024 | - | -$74.30 M(+2.7%) |
| Mar 2024 | - | -$72.36 M(+28.1%) |
| Dec 2023 | -$56.51 M(-173.6%) | -$56.51 M(+39.2%) |
| Sep 2023 | - | -$40.61 M(-792.5%) |
| Jun 2023 | - | $5.86 M(-88.9%) |
| Mar 2023 | - | $53.01 M(-31.0%) |
| Dec 2022 | $76.78 M(-65.4%) | $76.78 M(-39.5%) |
| Sep 2022 | - | $126.99 M(-22.7%) |
| Jun 2022 | - | $164.26 M(-15.3%) |
| Mar 2022 | - | $194.02 M(-12.5%) |
| Dec 2021 | $221.67 M(+7.2%) | $221.67 M(-9.7%) |
| Sep 2021 | - | $245.56 M(-8.2%) |
| Jun 2021 | - | $267.41 M(+43.2%) |
| Mar 2021 | - | $186.74 M(-9.7%) |
| Dec 2020 | $206.70 M | $206.70 M(-6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $220.94 M(+313.8%) |
| Jun 2020 | - | $53.39 M(-26.4%) |
| Mar 2020 | - | $72.59 M(+169.9%) |
| Dec 2019 | $26.89 M(-30.8%) | $26.89 M(-21.9%) |
| Sep 2019 | - | $34.42 M(+36.8%) |
| Jun 2019 | - | $25.16 M(-22.3%) |
| Mar 2019 | - | $32.37 M(-16.8%) |
| Dec 2018 | $38.89 M(-4060.2%) | $38.89 M(-15.1%) |
| Sep 2018 | - | $45.82 M(-8.0%) |
| Jun 2018 | - | $49.82 M(-4.4%) |
| Mar 2018 | - | $52.11 M(-5406.1%) |
| Dec 2017 | -$982.00 K(+203.1%) | -$982.00 K |
| Dec 2016 | -$324.00 K(-201.2%) | - |
| Jul 2016 | $320.20 K(-74.7%) | - |
| Jul 2015 | $1.27 M(-433.3%) | - |
| Jul 2014 | -$379.80 K | - |
FAQ
- What is BioXcel Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual shareholders equity year-on-year change?
- What is BioXcel Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly shareholders equity year-on-year change?
What is BioXcel Therapeutics annual stockholders equity?
The current annual shareholders equity of BTAI is -$56.51 M
What is the all time high annual shareholders equity for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual stockholders equity is $221.67 M
What is BioXcel Therapeutics annual shareholders equity year-on-year change?
Over the past year, BTAI annual stockholders equity has changed by -$133.28 M (-173.60%)
What is BioXcel Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of BTAI is -$85.63 M
What is the all time high quarterly shareholders equity for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly stockholders equity is $267.41 M
What is BioXcel Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, BTAI quarterly stockholders equity has changed by -$29.13 M (-51.54%)